Efficacy and safety of oral methazolamide in patients with type 2 diabetes : a 24-week, placebo-controlled, double-blind study

Simpson, R W; Nicholson, G C; Proietto, J; Sarah, A; Sanders, K M; Phillips, G; Chambers, J; Macginley, Rob; Orford, Neil; Walder, Ken; Krippner, G; Skoff, K; Wacher, V J

File(s) under permanent embargo

Efficacy and safety of oral methazolamide in patients with type 2 diabetes : a 24-week, placebo-controlled, double-blind study

journal contribution

posted on 2014-11-01, 00:00 authored by R W Simpson, G C Nicholson, J Proietto, A Sarah, K M Sanders, G Phillips, J Chambers, Rob Macginley, Neil OrfordNeil Orford, Ken WalderKen Walder, G Krippner, K Skoff, V J Wacher

To evaluate the safety and efficacy of methazolamide as a potential therapy for type 2 diabetes.

History

Journal

Diabetes Care

Volume

37

Issue

11

Pagination

3121 - 3123

Publisher

American Diabetes Association

Location

Alexandria VA.

Publisher DOI

https://doi.org/10.2337/dc14-1038

eISSN

1935-5548

Language

eng

Author URL

http://www.ncbi.nlm.nih.gov/pubmed/25125506

Publication classification

C Journal article; C1 Refereed article in a scholarly journal

Copyright notice

2014, American Diabetes Association

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Endocrinology & Metabolism FATTY LIVER-DISEASE

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

File(s) under permanent embargo

Efficacy and safety of oral methazolamide in patients with type 2 diabetes : a 24-week, placebo-controlled, double-blind study

History

Journal

Volume

Issue

Pagination

Publisher

Location

Publisher DOI

eISSN

Language

Author URL

Publication classification

Copyright notice

Usage metrics

Categories

Keywords

Licence

Exports